RNS Number : 8729Z
McBride PLC
18 September 2025
 

The following amendment has been made to the "Final Results" announcement released on 17 September 2025 at 7.00am under RNS No 5976Z. 

 

18 September 2025

 McBride plc

 

Ex-dividend date - Correction

McBride plc (the 'Company') announces a correction to the ex-dividend date noted in the Final Results announcement, released on 17 September 2025.  The times have been removed from the "Payment to shareholders" paragraph in the Final Results announcement so that it now reads as follows:

"Payments to shareholders

As a result of the refinancing of the revolving credit facility (RCF), the block on shareholder distributions has now been removed, permitting the Company to restore the payment of dividends and consider share buy-backs. The Board is recommending a final dividend of 3.0 pence per ordinary share for the year ended 30 June 2025, subject to approval by shareholders at the Company's 2025 AGM. If approved, the recommended final dividend will be paid as a cash dividend on 28 November 2025 to all holders of ordinary shares who are on the register of members on 31 October 2025. The ordinary shares will be marked as ex-dividend on 30 October 2025."

All other information in the Final Results announcement remains the same.

 

McBride plc

 

Chris Smith, Chief Executive Officer


Mark Strickland, Chief Financial Officer


 

 

Instinctif Partners

020 7457 2020

Hannah Scott

Galyna Kulachek


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLPMRTMTABMLA